Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Synthetic Nucleic Acid Supply & Synthesis

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract opportunity with the Advanced Research Projects Agency for Health (ARPA-H) under the Department of Health and Human Services involves the procurement of synthetic nucleic acids or the provision of benchtop synthesis equipment for prime contractors. The selected provider will be responsible for delivering synthetic DNA/RNA or installing synthesis hardware, ensuring all operations strictly adhere to the Office of Science and Technology Policy Framework for Nucleic Acid Synthesis Screening. The contract is categorized under NAICS code 325182 and is centered in Washington. Interested parties must submit their responses by the deadline of December 8, 2026, following the posting date of July 13, 2026.

General Info

ARPA-H subcontract for synthetic nucleic acids or benchtop equipment, due December 8, 2026.

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)View Agency

NAICS

325182 - Carbon Black ManufacturingView NAICS

Place of Performance

Washington, DC, USA

Set-Aside

NONE

Documents

This scope was carved out of ARPA-H-SOL-26-144.

The full solicitation package (9 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Technology InteGrator and AcceleratoR (TIGAR)

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies synthetic nucleic acids or benchtop synthesis equipment for prime contractors on ARPA-H projects. Procures synthetic DNA/RNA or provides synthesis hardware. Must adhere to the Office of Science and Technology Policy (OSTP) Framework for Nucleic Acid Synthesis Screening. Delivers synthetic nucleic acids or installed synthesis equipment.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541715
Federal
Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Program
Solicitation # 7599226SN106
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals from small business concerns (SBCs) through its Fiscal Year 2026 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. This total small business set-aside initiative aims to stimulate technological innovation and increase private sector commercialization of high-impact health solutions. Eligible SBCs must be organized for profit in the United States and have no more than 500 employees. The program is structured in two primary phases: Phase I focuses on feasibility and typically has a one-year period of performance, while Phase II involves full research and development with a heavy emphasis on commercialization activities, including regulatory objectives and market strategies. The solicitation covers seven specific research topics: developing an annual fertility test for women, creating versatile bioadhesives, building a universal synthetic biology platform for toxin removal, developing non-surgical therapies for endometriosis, advancing ARPA-H lineage technologies, creating rapid diagnostics for multi-system autoimmune diseases, and developing a virtual human brain for neurosurgical robotics. The application process is a two-stage submission via the ARPA-H Solutions site. Stage 1 requires a solution summary, with additional feasibility or commercialization statements for Direct-to-Phase II or Fast Track applicants. Invited proposers move to Stage 2, which requires a cost proposal, a Task Description Document, a Gantt chart, and a technical presentation limited to 16 slides. Awards are based on a selectability determination where strengths must outweigh weaknesses across factors including technical merit, novelty, team experience, and path to impact. Funding is managed through fixed payment milestones based on the government's acceptance of deliverables. Proposers must maintain active SAM.gov registration and a Unique Entity Identifier. Technical and Business Assistance (TABA) funding is available, capped at $6,500 for Phase I and $50,000 for Phase II. All contracts are subject to HHS accessibility standards and specific foreign affiliation disclosure requirements.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

in 21 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS